At the end of psoriasis (Day 7), only Iristatin kept its inhibitory effect on IL-23 expression, while Mialostatin significantly increased it, while sialostatin L and Sialostatin L2 didn’t show any effect. This evidence concerns the gene IL23A and psoriasis.